Navigation Links
Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
Date:8/27/2008

leevec and Novartis Oncology can be found on the websites http://www.novartisoncologyvpo.com, http://www.gleevec.com, http://www.us.tasigna.com and http://www.novartisoncology.us.

References

1. Fast Track, Priority Review and Accelerated Approval. US Food and Drug Administration - Center for Drug Evaluation and Research. http://www.accessdata.fda.gov/scripts/cder/onctools/Accel.cfm. Accessed 31 July 2008.

2. Internal data.

3. Z9001: A Phase III Randomized Double-blind Study of Adjuvant STI571 (Gleevec(R)) Versus Placebo in Patients Following the Resection of Primary Gastrointestinal Stromal Tumor (GIST). http://www.cancer.gov/clinicaltrials/ACOSOG-Z9001. Accessed June 2008.

4. Van den Abbeele A., Benjamin R., Blanke C, et al. Clinical Management of GIST. Recurrence patterns and prognostic factors for survival. 2003;1-24.

5. American Cancer Society. Cancer Reference Information. Detailed Guide for Gastrointestinal Stromal Tumors. Key Statistics. http://www.cancer.org/docroot/CRI/content/CRI_2_4_1x_What_Are_the_Key_Stati sti cs_About_Gastrointestinal_Stromal_Tumors.asp?rnav=cri. Accessed 22 February 2008.

6. US Department of Health and Human Services. Agency for Healthcare Research and Quality (AHRQ). Technology Assessment: Report on the Relative Efficacy of Oral Cancer Therapy for Medicare Beneficiaries Versus Currently Covered Therapy, Part 2. Imatinib for Gastrointestinal Stromal Tumors (GISTs). Available at:

SOURCE Novartis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia
2. TorreyPines Therapeutics Receives NASDAQ Deficiency Notice
3. Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
4. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
5. Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents
6. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
7. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
8. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
9. SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms
10. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
11. Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... the Rx Club, the Daveys, the GLOBALS, ,and PM360 Pharma ... ... December 17, 2009 -- Chicago-based full-service healthcare communications agency Goble ... marketing awards programs honoring exceptional creative and interactive work. , ... G&A with 9 Awards of Excellence for the following creative ...
(Date:12/17/2009)... will develop proprietary medical food, functional food, and dietary supplement ... markets , ... North Brunswick, NJ ... a biotechnology company at the crossroads of foods and pharmaceuticals, ... pleased to announce the signing of a Memorandum of Understanding ...
(Date:12/16/2009)... a simple, cheap, accurate test to find undetected landmines. ... a custom-made bacteria that glows green when it comes ... The bacteria can be mixed into a colourless solution ... patches to indicate the presence of landmines. , ... produce, could be delivered from the air onto areas ...
(Date:12/16/2009)... found that certain cardiac pacemakers may inadequately stimulate ... imaging (MRI) scan due to the magnetic pulses ... This inadequate stimulation is potentially dangerous for ... research published in BioMed Central,s open access journal ... an imaging technique that uses a magnetic field ...
Breaking Biology Technology:Goble & Associates Creative Work Awarded at Advertising Industry Competitions 2Goble & Associates Creative Work Awarded at Advertising Industry Competitions 3Goble & Associates Creative Work Awarded at Advertising Industry Competitions 4WellGen, Inc. and RFI Ingredients to Collaborate on Therapeutic Nutrition Opportunities 2WellGen, Inc. and RFI Ingredients to Collaborate on Therapeutic Nutrition Opportunities 3FDA researchers identify new MRI safety risk for patients with pacemakers 2
... will release its third quarter 2007 financial results on ... will be available,on the PPD Web site at ... October 24, at 9 a.m. ET, PPD will conduct ... results and the,overall business environment. A Q&A session will ...
... LAVAL, QC, Sept. 28 /PRNewswire-FirstCall/ - Neptune Technologies ... report its,financial results for the fiscal year ended ... improved its productivity and operational,profitability while continuing its ... Asian markets, resulting in,sustainable sales growth. Financial ...
... Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced ... a U.K. Phase Ia/Ib combination,REOLYSIN(R) and radiation ... cancers is scheduled to be presented at ... October 2, 2007 in Birmingham, U.K.,The presentation, ...
Other Biology Technology:PPD Announces Third Quarter 2007 Earnings Release, Webcast and Conference Call 2Neptune Reports Year End Financial Results - Neptune Records 18% Sales Increase and 43% EBITDA Increase in Year End Results 2Neptune Reports Year End Financial Results - Neptune Records 18% Sales Increase and 43% EBITDA Increase in Year End Results 3Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial 2Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial 3Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial 4
(Date:12/16/2009)... DigitalPersona, Inc., a leader in ... an agreement with IBM to deploy a ... technology on IBM SurePOS 500 retail systems. ... applications to more easily and quickly identify ... linked to the individuals who perform them. ...
(Date:12/16/2009)... IgeaCare Solutions Inc. is pleased to ... healthcare communications company previously operating as IgeaCare Systems ... move forward under new leadership and funding. ,, ... to the position of Chief Executive Officer. Under ... providing a superior servicing and support model; fast ...
(Date:12/16/2009)... Va., Dec. 9 CSC (NYSE: ... the American Association for Laboratory Accreditation awarded ... (ISO/IEC) 17025:2005 accreditation to the company,s Test ... Identity Labs located in Fairmont, W.Va. The ... laboratory in the world to achieve this ...
Breaking Biology News(10 mins):DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation 2Weber Shandwick Chosen By National Marrow Donor Program 28R 29 To Head Awareness Campaign 47925 1Weber Shandwick Chosen By National Marrow Donor Program 28R 29 To Head Awareness Campaign 47925 2Weber Shandwick Chosen By National Marrow Donor Program 28R 29 To Head Awareness Campaign 47925 3MD On Line Inc Acquires Medical Claim Corp 47920 1MD On Line Inc Acquires Medical Claim Corp 47920 2Jefferson researchers identify critical marker of response to gemcitabine in pancreatic cancer 47918 1Jefferson researchers identify critical marker of response to gemcitabine in pancreatic cancer 47918 2
... A new study has found that large segments of ... phytoplankton growth and the absence of the mineral stresses ... pigments that make ocean productivity appear more robust than ... of satellite chlorophyll data may be inaccurate, the researchers ...
... relatively benign compound contained in a widely used group ... of existing pesticides in the environment, according to a ... California, Berkeley. , While the increase in toxicity was ... were unexpected, the researchers said. , The study's results, ...
... researchers has created technology to regrow teeth--the first time ... , Using low-intensity pulsed ultrasound (LIPUS), Dr. Tarak El-Bialy ... Jie Chen and Dr. Ying Tsui from the Faculty ... a non-invasive and novel way to stimulate jaw growth ...
Other Biology News:Iron critical to ocean productivity, carbon uptake 2Iron critical to ocean productivity, carbon uptake 3Mosquito spray increases toxicity of pyrethroids in creek, study finds 2Mosquito spray increases toxicity of pyrethroids in creek, study finds 3Mosquito spray increases toxicity of pyrethroids in creek, study finds 4Ultrasound may help regrow teeth 2